Histamine release from human basophils by pepstatin A

Agents Actions. 1985 Jul;16(5):306-9. doi: 10.1007/BF01982863.

Abstract

Pepstatin A, a pentapeptide isolated from cultures of actinomycetes, induced histamine secretion from human basophils in the concentration range of 3 X 10(-7) to 10(-4) M. The characteristics of this reaction were similar to those of f-met-peptide-induced histamine release: pepstatin A-induced release required Ca2+ and the release reaction was complete within 2 min at 22 or 37 degrees C, but did not occur at 4 degrees C. Release by both pepstatin A and f-met-peptide was reversibly inhibited by two non-releasing analogs of f-met-peptide, CBZ-Phe-Met and BOC-Met-Leu-Phe. Further, there was complete cross-desensitization between pepstatin A and f-met-peptide, while cells desensitized to pepstatin A released normally with anti-IgE and vice versa. A variety of pharmacological agents had similar effects on both pepstatin A and f-met-peptide-induced release (e.g., no enhancement with D2O; marked enhancement with cytochalasin B). We suggest that pepstatin A induces histamine release from human basophils by activating a cell surface receptor(s), also activated by the synthetic tripeptide f-met-peptide.

Publication types

  • Comparative Study

MeSH terms

  • Basophils / drug effects
  • Basophils / metabolism*
  • Cytochalasin B / pharmacology
  • Deuterium / pharmacology
  • Dipeptides / pharmacology
  • Dose-Response Relationship, Drug
  • Histamine Release / drug effects*
  • Humans
  • Immunoglobulin E / physiology
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Oligopeptides / pharmacology*
  • Pepstatins / pharmacology*

Substances

  • Dipeptides
  • Oligopeptides
  • Pepstatins
  • Streptomyces pepsin inhibitor
  • carbobenzoxyphenylalanylmethionine
  • Immunoglobulin E
  • Cytochalasin B
  • N-Formylmethionine Leucyl-Phenylalanine
  • t-butyloxycarbonyl-methionyl-leucyl-phenylalanine
  • Deuterium
  • pepstatin